Ku et al. emphasized that overexpressed EZH2 in prostate-specific Pten-Rb1-p53 triple knockout mice plays a pivotal role in promoting prostate cancer lineage plasticity, antiandrogen resistance, and neuroendocrine phenotype (26). Here, EZH2 is linked to prostate cancer.